Malignant retroperitoneal fibrosis in lung adenocarcinoma

Código QR

Malignant retroperitoneal fibrosis in lung adenocarcinoma

Guardado en:

Detalles Bibliográficos
Autores principales:	Natalie Uy, Christina Baik
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/5a0092fc7df14f43bb4cdced88dd1ee6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Hepatoid Adenocarcinoma of the Lung
por: Meihui Li, et al.
Publicado: (2021)

Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
por: Dana S. Neel, et al.
Publicado: (2017)

Characterization of evolution trajectory and immune profiling of brain metastasis in lung adenocarcinoma
por: Tao Jiang, et al.
Publicado: (2021)

Gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapy
por: Sugiura Y, et al.
Publicado: (2013)

MiR-186 Suppressed Growth, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting Dicer1
por: Juan Wang, et al.
Publicado: (2021)

Preoperative clinical and tumor genomic features associated with pathologic lymph node metastasis in clinical stage I and II lung adenocarcinoma
por: Raul Caso, et al.
Publicado: (2021)

Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient
por: Maurício Fernando Silva Almeida Ribeiro, et al.
Publicado: (2021)

Construction of a circRNA-miRNA-mRNA Regulated Pathway Involved in EGFR-TKI Lung Adenocarcinoma Resistance
por: Chenyue Dai MM, et al.
Publicado: (2021)

EGFR mutations in patients with lung adenocarcinoma in southwest China: are G719S/A and L861Q more likely detected in tumors derived from smokers?
por: Wang QS, et al.
Publicado: (2013)

Differentiation therapy for myeloid malignancies: beyond cytotoxicity
por: Ryan J. Stubbins, et al.
Publicado: (2021)

Asian gastric cardia adenocarcinoma: A distinct and understudied cancer with etiologic similarities to both esophageal squamous cell carcinoma and noncardia gastric adenocarcinoma
por: Christian C. Abnet
Publicado: (2021)

Malignant neoplasm of the bronchi and lung: Russian clinical guidelines
por: Konstantin K. Laktionov, et al.
Publicado: (2021)

Endothelial cell malignancies: new insights from the laboratory and clinic
por: Michael J. Wagner, et al.
Publicado: (2017)

Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma
por: Michelle R. Goulart, et al.
Publicado: (2021)

Gastroesophageal junction adenocarcinoma displays abnormalities in homologous recombination and nucleotide excision repair
por: Dewalt RI, et al.
Publicado: (2014)

Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor
por: Sumanth Nagabushan, et al.
Publicado: (2021)

Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation
por: Kang Wang, et al.
Publicado: (2021)

Lung cancer in women
por: Barrera-Rodriguez R, et al.
Publicado: (2012)

A Successful Chemoembolization of a Retroperitoneal Soft Tissue Sarcoma: A Case Report
por: Waldec Jorge David Filho, et al.
Publicado: (2021)

Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma
por: Haxho F, et al.
Publicado: (2014)

Risk of second primary malignancies in patients with follicular lymphoma: a population-based study in the Netherlands, 1989-2018
por: Manette A. W. Dinnessen, et al.
Publicado: (2021)

Second Primary Malignancies in Patients with Pancreatic Neuroendocrine Neoplasms: A Population-Based Study on Occurrence, Risk Factors, and Prognosis
por: Tulan Hu, et al.
Publicado: (2021)

Update on biomarkers for the detection of lung cancer
por: Jantus-Lewintre E, et al.
Publicado: (2012)

Comprehensive review of fetal adenocarcinoma of the lung
por: Ricaurte LM, et al.
Publicado: (2018)

Correction to: MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
por: Guangbing Xiong, et al.
Publicado: (2021)

JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
por: Nobukazu Fujimoto, et al.
Publicado: (2021)

Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study
por: Tai-Jan Chiu, et al.
Publicado: (2021)

Staging lung cancer: role of endobronchial ultrasound
por: Inage T, et al.
Publicado: (2014)

Rare deleterious germline variants and risk of lung cancer
por: Yanhong Liu, et al.
Publicado: (2021)

Effectiveness of maintenance treatments for nonsmall cell lung cancer
por: Eadens MJ, et al.
Publicado: (2011)

Microbiome dysbiosis in lung cancer: from composition to therapy
por: Ning-Ning Liu, et al.
Publicado: (2020)

PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma
por: Naoya Maekawa, et al.
Publicado: (2021)

Afatinib treatment in advanced non-small cell lung cancer
por: Hurwitz JL, et al.
Publicado: (2011)

Non-small cell lung cancer: the era of targeted therapy
por: Antonoff MB, et al.
Publicado: (2012)

The Earliest Stage of Lung Adenocarcinoma:  the Pathological Diagnosis and Clinical Significance of Adenocarcinoma In Situ
por: Huikang XIE, et al.
Publicado: (2021)

Clinical application of a lung cancer organoid (tumoroid) culture system
por: Etsuko Yokota, et al.
Publicado: (2021)

Epiregulin as a therapeutic target in non-small-cell lung cancer
por: Sunaga N, et al.
Publicado: (2015)

Potential toxicity and safety evaluation of nanomaterials for the respiratory system and lung cancer
por: Vlachogianni T, et al.
Publicado: (2013)

Emerging treatment options in the management of non-small cell lung cancer
por: Filosso PL, et al.
Publicado: (2011)

The voice of postsurgical lung cancer patients regarding supportive care needs
por: Hoffman AJ, et al.
Publicado: (2014)